Saved source record
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.
This is a source-metadata record last found in a complete check on Sep 28, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.
Study metadata
- Study type
- Original study
- Study category (metadata hint)
- Human
- Source date
- Published: 2023 Apr
- Authors
- Lingvay I, Cheng AY, Levine JA, Gomez-Valderas E, Allen SE, Ranta K, Torcello-Gómez A, Thieu VT
- Journal or registry
- Diabetes, obesity & metabolism
- Registry study design
- Not reported
- Registry enrollment
- Not reported
- Funding agencies
- Eli Lilly and Company
- Identifiers
- DOI: 10.1111/dom.14943 · PMID: 36514843
- First found
- Sep 28, 2026
- Last found
- Sep 28, 2026
Original sources
Browse saved studies · Search live sources